The product can not be sold in a country where it is illegal.

Buy Zaleplon for sale online from USA vendor

Specification
Product Name: Zaleplon
IUPAC Name: N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide
Other Names: Sonata, Starnoc, Andante
Molecular Formula: None
Molar Mass: 237.26 g·mol−1
Effect: stimulant, psychedelic
Purity of the substance: 99.9%
Physical properties: Crystals, Powder
In Stock
Shipping:
- FREE 7 days from China
- INSURANCE option is local shipping from distributor in your country. FREE & 3 Day Shipping
Payments: WU, MG, Bank Transfer , Pay with Bitcoin - get 10% OFF
Get FREE five samples 2 grams each for the main order.
100g
$510
200g
$720
300g
$850
500g
$1300
2000g
$3600
1000g
$2100
  • Zaleplon for sale online from USA vendor

Table of Contents

  1. Understanding Zaleplon (Sonata)
    • Introduction to Zaleplon
    • Zaleplon in Context: Z-drugs
    • Pharmacological Profile
  2. Dosage and Bioavailability
    • Dosage Recommendations
    • Bioavailability of Zaleplon
  3. Subjective Effects
    • Physical Effects
    • Disconnective Effects
    • Visual Effects
    • Cognitive Effects
    • Auditory Effects
  4. Toxicity and Harm Potential
  5. Tolerance and Addiction Potential
  6. Dangerous Interactions
  7. Legal Status

Understanding Zaleplon (Sonata): A Non-benzodiazepine Hypnotic

Introduction to Zaleplon

Zaleplon, commonly marketed under the trade name Sonata, belongs to the category of non-benzodiazepine hypnotic drugs. It falls within the hypnotic and depressant psychoactive classes and is chemically categorized as a pyrazolopyrimidine compound. Often, when individuals consume Zaleplon recreationally, they exceed prescribed doses, leading to the manifestation of potent and unconventional effects, including hallucinations, hypnotic states, delirium, and sometimes even psychedelic experiences. Some users may opt for alternative administration methods, such as insufflation, to hasten the onset of effects.

Zaleplon in Context: Z-drugs

Zaleplon is part of a pharmaceutical family referred to as "Z-drugs," which also encompasses zolpidem (Ambien) and zopiclone. These medications were developed with the intention of exhibiting more selective hypnotic actions compared to traditional benzodiazepines.

Pharmacological Profile

Zaleplon's pharmacological characteristics closely resemble those of benzodiazepines. It acts as a full agonist on the benzodiazepine a1 receptor, located within the GABAA receptor ionophore complex in the brain. While it exhibits lower affinity for the a2 and a3 subtypes, it effectively enhances the action of gamma-aminobutyric acid (GABA) in a manner similar to, but more selectively than, benzodiazepines.

The precise pharmacological mechanisms responsible for inducing the unusual hallucinogenic effects of Zaleplon are not thoroughly understood and have not been directly studied. However, it is speculated that Zaleplon may share similar mechanisms as a GABAA receptor agonist with muscimol, the active compound found in hallucinogenic Amanita muscaria mushrooms.

Subjective Effects

Note: The following subjective effects are derived from the Subjective Effect Index (SEI), a compilation of anecdotal user reports and analyses by PsychonautWiki contributors. These effects should be approached with caution and skepticism.

It is crucial to acknowledge that the occurrence of these effects may not follow a predictable or consistent pattern. However, higher doses increase the likelihood of experiencing the full spectrum of effects, which may include addiction, severe injury, or even death.

Understanding Zaleplon (Sonata): Dosage and Bioavailability

Dosage Recommendations

Zaleplon (Sonata) is typically prescribed for short-term use due to its hypnotic properties. However, when individuals consume it for recreational purposes, they often exceed recommended doses. Below are dosage guidelines based on subjective experiences:

  • Threshold: 5 mg
  • Light: 10 - 30 mg
  • Common: 30 - 60 mg
  • Strong: 60 - 100 mg
  • Heavy: 100 mg and above

Bioavailability of Zaleplon

The bioavailability of Zaleplon, which refers to the fraction of the administered dose that reaches systemic circulation, is approximately 30% ± 10%. This means that around 30% of the ingested dose of Zaleplon enters the bloodstream.

Understanding Zaleplon (Sonata): Subjective Effects

Physical Effects

The physical effects of Zaleplon resemble those of benzodiazepines, such as alprazolam, albeit with less pronounced muscle relaxation. These effects encompass:

  • Sedation: Zaleplon induces significant sedation, making it a commonly prescribed sleep aid for individuals struggling with insomnia.
  • Physical Euphoria: Users may experience a warm, gentle sensation radiating from their body's core.
  • Appetite Enhancement: Binge eating of peculiar food combinations during a state resembling sleep, often with little or no recollection upon waking.
  • Gustatory Hallucinations
  • Dizziness
  • Headaches
  • Nausea: Particularly at moderate to heavy doses, often relieved after vomiting.
  • Muscle Relaxation: Although present, it typically manifests more prominently at higher doses compared to benzodiazepines.
  • Motor Control Loss
  • Respiratory Depression
  • Increased Heart Rate
  • Increased Blood Pressure
  • Seizure Suppression
  • Stomach Cramps

Disconnective Effects

  • Visual Disconnection: Occurring at moderate to heavy doses, akin to dissociatives like DXM and ketamine. Users may perceive their vision as distant or vague, resembling viewing through a screen or window.
  • Consciousness Disconnection: Also present at moderate to heavy doses, comparable to dissociatives, though not as profound. Users may experience a sense of detachment from reality.

Visual Effects

The visual effects of Zaleplon share similarities with aspects of deliriants, dissociatives, and psychedelics. These effects include:

  • Double Vision
  • Object Activation
  • Acuity Suppression
  • Drifting: At higher doses, surroundings may appear to melt and distort akin to traditional psychedelics.
  • Internal Hallucinations: Vivid, dream-like states, akin to deliriants, extending with dosage.
  • External Hallucinations: Occurring at heavy doses, comparable to deliriants like DPH and datura.

Cognitive Effects

Zaleplon's cognitive effects are akin to benzodiazepines, with less pronounced anxiety suppression. At recreational doses, additional effects reminiscent of deliriants may manifest, including:

  • Amnesia
  • Anxiety Suppression
  • Compulsive Redosing
  • Cognitive Euphoria
  • Psychosis
  • Delusions: Particularly at heavy doses, comparable to traditional deliriants.
  • Delusions of Sobriety
  • Disinhibition
  • Dream Potentiation
  • Laughter
  • Mania
  • Déjà Vu
  • Confusion
  • Increased Music Appreciation
  • Suggestibility Enhancement
  • Analysis Suppression
  • Language Suppression
  • Short-Term Memory Suppression
  • Thought Deceleration
  • Thought Disorganization
  • Focus Suppression

Auditory Effects

  • Auditory Hallucinations: At heavier doses, users may perceive imagined sounds such as voices or music.

Toxicity and Harm Potential

Zaleplon, by itself, likely has low toxicity relative to dose. However, it can be lethal when combined with depressants like benzodiazepines, alcohol, or opioids. As with other Z-drugs, Zaleplon use may lead to bizarre and dangerous behavior.

Tolerance and Addiction Potential

Zaleplon is moderately physically and psychologically addictive. Tolerance develops within weeks of daily use, returning to baseline within 7-14 days after cessation. Withdrawal symptoms may occur after abrupt cessation, necessitating gradual dose reduction.

Dangerous Interactions

Zaleplon can interact dangerously with various substances, particularly depressants and dissociatives, potentiating their effects and increasing the risk of respiratory depression and loss of consciousness.

Legal Status

  • EU: Zaleplon was withdrawn within the EU.
  • Switzerland: Withdrawn in Switzerland in 2011.
  • United States: Schedule IV under the Controlled Substance Act, illegal without a prescription.
  • Canada: Not scheduled, but may be illegal without a prescription.
  • Russia: Available with a prescription.

Frequently Asked Questions (FAQ)

Q: What is Zaleplon (Sonata)?

A: Zaleplon, sold under the brand name Sonata, is a non-benzodiazepine hypnotic drug primarily prescribed for short-term treatment of insomnia.

Q: How does Zaleplon compare to other Z-drugs?

A: Zaleplon belongs to a class of drugs known as Z-drugs, which also includes zolpidem (Ambien) and zopiclone. These drugs were developed to offer more selective hypnotic actions compared to traditional benzodiazepines.

Q: What are the common dosage ranges for Zaleplon?

A: The typical dosage ranges for Zaleplon are as follows:

  • Threshold: 5 mg
  • Light: 10 - 30 mg
  • Common: 30 - 60 mg
  • Strong: 60 - 100 mg
  • Heavy: 100 mg and above

Q: What are the potential subjective effects of Zaleplon?

A: Subjective effects of Zaleplon include physical effects such as sedation, euphoria, and appetite enhancement, as well as disconnective effects like visual disconnection and consciousness disconnection. It can also induce visual, cognitive, and auditory effects.

Q: Is Zaleplon safe to use?

A: While Zaleplon itself has low toxicity relative to dose, it can be dangerous when combined with other depressants like benzodiazepines, alcohol, or opioids. Additionally, Zaleplon use may lead to tolerance, addiction, and potentially harmful interactions.

Q: What is the legal status of Zaleplon?

A: The legal status of Zaleplon varies by country. In the United States, it is classified as a Schedule IV controlled substance, meaning it has some potential for abuse and possession without a prescription is illegal.

1kg $1590

500g $1080

out of stock

1kg $1690

1kg $1590

out of stock

1kg $1590

1kg $2400

500g $1199

out of stock

[